Centre for Pharmaceutical Engineering Science wins ICURe Market Validation funding for its innovative 'FastAct' Technology
The team at CPES has recently developed "FastAct" Technology which is a ground breaking invention related to enhanced bioavailability of drugs. FastAct is targeted to address poorly soluble actives in the pharmaceutical, nutraceutical and agrochemical sectors.